Beneficial effects of the novel cholecystokinin agonist (pGlu-Gln)-CCK-8 in mouse models of obesity/diabetes

Incretin physiology beyond glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: cholecystokinin and gastrin peptides

(2011) J. F. Rehfeld   Acta Physiologica

Impaired Insulin Secretion and Enhanced Insulin Sensitivity in Cholecystokinin-Deficient Mice

(2011) C.-M. Lo et al.   DIABETES

The future of incretin-based therapy: novel avenues-novel targets

(2011) B. Ahrén   DIABETES OBESITY & METABOLISM

Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis

(2011) Safina Ali et al.   JOURNAL OF CLINICAL INVESTIGATION

Active immunization against (Pro3)GIP improves metabolic status in high-fat-fed mice

(2010) I. A. Montgomery et al.   DIABETES OBESITY & METABOLISM

Cholecystokinin Is Up-Regulated in Obese Mouse Islets and Expands β-Cell Mass by Increasing β-Cell Survival

(2010) Jeremy A. Lavine et al.   ENDOCRINOLOGY

Regulation of pancreatic islet gene expression in mouse islets by pregnancy

(2010) B T Layden et al.   JOURNAL OF ENDOCRINOLOGY

Fatty acid derivatised analogues of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic properties

(2009) Barry D. Kerr et al.   BIOCHEMICAL PHARMACOLOGY

Stimulation of Cholecystokinin-A Receptors With Gl181771X: A Failed Clinical Trial That Did Not Test the Pharmacogenetic Hypothesis for Reduction of Food Intake

(2009) AD Roses   CLINICAL PHARMACOLOGY & THERAPEUTICS

Recent Advances in Antidiabetic Drug Therapies Targeting the Enteroinsular Axis

(2009) P. Flatt et al.   CURRENT DRUG METABOLISM

Gut hormones: Implications for the treatment of obesity

(2009) Marianne T. Neary et al.   PHARMACOLOGY & THERAPEUTICS

PEGylated cholecystokinin is more potent in inducing anorexia than conditioned taste aversion in rats

(2008) I Verbaeys et al.   BRITISH JOURNAL OF PHARMACOLOGY

The incretin system and its role in type 2 diabetes mellitus

(2008) J HOLST et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Lack of tolerance development with long-term administration of PEGylated cholecystokinin

(2008) Isabelle Verbaeys et al.   PEPTIDES

PEGylated cholecystokinin prolongs satiation in rats: dose dependency and receptor involvement

(2007) I Verbaeys et al.   BRITISH JOURNAL OF PHARMACOLOGY